Clinical trial
Dexmedetomidine Hydrochloride in the Prevention of Organ Failure Following
NCT02691598 is registered in ClinicalTrials.gov with Nanjing University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexmedetomidine Hydrochloride in the Prevention of Organ Failure Following
- Lead sponsor
- Nanjing University School of Medicine
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- February 29, 2016
- Completion date
- August 31, 2017
- Enrollment
- 314 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.